MicroRNA-30e Reduces Cell Growth and Enhances Drug Sensitivity to Gefitinib in Lung Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 20

PMID 27992364

Citations 11

Authors

Zhi-Qiang Ning

Hai-Lin Lu

Chao Chen

Lin Wang

Wei Cai

Yan Li

Ting-Hua Cao

Jing Zhu

Yong-Qian Shu

Hua Shen

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) play critical roles in variousbiological processes,including malignancy. Here, we demonstrated that miR-30e levels were markedly reduced in human lung carcinoma specimens in comparisonwith adjacent normal tissues.In addition, miR-30eamounts were starkly lower in the resistant PC9/gefitinib (PC9G) cancer cells compared with PC9 cells. Meanwhile, miR-30eoverexpression inPC9G cells resulted in reduced cell proliferation and migration,reversing drug resistance to gefitinib.Conversely,miR-30e silencing in PC9 cells increased proliferation as well as migration, and conferred resistance to gefitinib.Moreover, HOXA1, which was identified asa new miR-30etarget, plays important roles in regulating cell fate, early developmental patterns and organogenesis.Importantly, miR-30ealso inhibited PC9G growth in vivo. Taken together, these findings demonstrated that miR-30eshould be considered a tumor suppressor miRNA, which could be used in treatinghuman lung cancer.

Citing Articles

Exploring the Expression of Pro-Inflammatory and Hypoxia-Related MicroRNA-20a, MicroRNA-30e, and MicroRNA-93 in Periodontitis and Gingival Mesenchymal Stem Cells under Hypoxia.

Chaparro A, Lozano M, Gaedechens D, Lopez C, Albers D, Hernandez M Int J Mol Sci. 2022; 23(18).

PMID: 36142220 PMC: 9499533. DOI: 10.3390/ijms231810310.

MicroRNA therapeutic targets in neonatal hypoxic-ischemic brain injury: a narrative review.

Peeples E Pediatr Res. 2022; 93(4):780-788.

PMID: 35854090 DOI: 10.1038/s41390-022-02196-4.

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma.

Han J, Sun W, Liu R, Zhou Z, Zhang H, Chen X Front Oncol. 2020; 10:1495.

PMID: 33072545 PMC: 7531016. DOI: 10.3389/fonc.2020.01495.

MicroRNA-30e-5p has an Integrated Role in the Regulation of the Innate Immune Response during Virus Infection and Systemic Lupus Erythematosus.

Mishra R, Bhattacharya S, Rawat B, Kumar A, Kumar A, Niraj K iScience. 2020; 23(7):101322.

PMID: 32688283 PMC: 7371751. DOI: 10.1016/j.isci.2020.101322.

Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.

Xiong R, Sun X, Wu H, Xu G, Wang G, Sun X Thorac Cancer. 2019; 11(1):156-165.

PMID: 31777195 PMC: 6938762. DOI: 10.1111/1759-7714.13258.

References

Wu F, Zhu S, Ding Y, Beck W, Mo Y . MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res. 2009; 15(5):1550-7. PMC: 2846614. DOI: 10.1158/1078-0432.CCR-08-0820. View

Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S . miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008; 123(2):372-379. DOI: 10.1002/ijc.23501. View

Shen H, Wang L, Ge X, Jiang C, Shi Z, Li D . MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer. Oncotarget. 2016; 7(15):20728-42. PMC: 4991488. DOI: 10.18632/oncotarget.8011. View

Shen H, Yu X, Yang F, Zhang Z, Shen J, Sun J . Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling. PLoS Genet. 2016; 12(8):e1006244. PMC: 4991802. DOI: 10.1371/journal.pgen.1006244. View

Wang L, Jiang C, Li D, Ge X, Shi Z, Li C . MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1. Oncotarget. 2015; 7(3):2660-71. PMC: 4823062. DOI: 10.18632/oncotarget.6545. View

Rice K, Licht J . HOX deregulation in acute myeloid leukemia. J Clin Invest. 2007; 117(4):865-8. PMC: 1838955. DOI: 10.1172/JCI31861. View

Wang H, Liu G, Shen D, Ye H, Huang J, Jiao L . HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells. Oncol Rep. 2015; 34(3):1203-10. DOI: 10.3892/or.2015.4085. View

Pan B, Feng B, Chen Y, Huang G, Wang R, Chen L . MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma. Oncotarget. 2015; 6(32):32805-20. PMC: 4741731. DOI: 10.18632/oncotarget.5352. View

Ambros V . MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003; 113(6):673-6. DOI: 10.1016/s0092-8674(03)00428-8. View

10.

Gibson N . Engineered microRNA therapeutics. J R Coll Physicians Edinb. 2014; 44(3):196-200. DOI: 10.4997/JRCPE.2014.302. View

11.

Shah N, Sukumar S . The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010; 10(5):361-71. DOI: 10.1038/nrc2826. View

12.

Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Raanani P . MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein. Cancer Lett. 2014; 356(2 Pt B):597-605. DOI: 10.1016/j.canlet.2014.10.006. View

13.

Ambros V, Lee R . Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol. 2004; 265:131-58. DOI: 10.1385/1-59259-775-0:131. View

14.

Ye Z, Yin S, Su Z, Bai M, Zhang H, Hei Z . Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2. Oncotarget. 2016; 7(25):37524-37535. PMC: 5122329. DOI: 10.18632/oncotarget.6852. View

15.

Cillo C, Cantile M, Faiella A, Boncinelli E . Homeobox genes in normal and malignant cells. J Cell Physiol. 2001; 188(2):161-9. DOI: 10.1002/jcp.1115. View

16.

Delval S, Taminiau A, Lamy J, Lallemand C, Gilles C, Noel A . The Pbx interaction motif of Hoxa1 is essential for its oncogenic activity. PLoS One. 2011; 6(9):e25247. PMC: 3177904. DOI: 10.1371/journal.pone.0025247. View

17.

Brock A, Krause S, Li H, Kowalski M, Goldberg M, Collins J . Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med. 2014; 6(217):217ra2. PMC: 5546412. DOI: 10.1126/scitranslmed.3007048. View

18.

Wang L, Shi Z, Jiang C, Liu X, Chen Q, Qian X . MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget. 2014; 5(14):5416-27. PMC: 4170647. DOI: 10.18632/oncotarget.2116. View

19.

Lynch T, Bell D, Sordella R, Gurubhagavatula S, Okimoto R, Brannigan B . Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350(21):2129-39. DOI: 10.1056/NEJMoa040938. View

20.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View